Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid ...
RCC trials are predominantly conducted in high-income countries, neglecting low-income regions where poverty affects outcomes. Lack of diversity in clinical trials limits understanding of drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results